$3.85
Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
Clene to Present at Upcoming September Investor Conferences
Clene Eyes Q4 NDA for ALS Drug After FDA-Requested Biomarker Analyses
Clene to Present at the Emerging Growth Conference
Overview
52-week range
$3.72
$14
1% of range
Avg surprise (last 3)
+11.1%
Avg reaction (last 2)
-1.0%
50% positive
Latest IV / EM
624%
EM ±119.4% · $5 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.31 | $-0.50 | +38.0% | +38.0% | +8.5% | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.78 | $-0.49 | -59.2% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-0.50 | $-1.10 | +54.5% | — | -10.5% | earnings |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $90,000 | $15,000 | — | $15,000 | $27,000 | $81,000 | — | $87,000 |
| Cost of revenue | $36,000 | $0 | — | $0 | $0 | $20,000 | — | $18,000 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-5M | $-2M | — | $-6M | $-6M | $-4M | — | $-8M |
| Net income | $-13M | $-8M | — | $-9M | $-7M | $-751,000 | — | $-8M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10M | $6M | $5M | $8M | $7M | $10M | $12M | $15M |
| Inventory | $37,000 | $54,000 | $37,000 | $61,000 | $79,000 | $38,000 | $68,000 | $128,000 |
| Total current assets | $15M | $13M | $9M | $13M | $12M | $15M | $16M | $20M |
| Total assets | $23M | $22M | $18M | $22M | $22M | $25M | $27M | $32M |
| Long-term debt | $18M | $18M | — | $18M | $16M | $17M | — | — |
| Total liabilities | $48M | $40M | $36M | $35M | $31M | $30M | $36M | $36M |
| Total equity | $-25M | $-19M | $-18M | $-12M | $-9M | $-5M | $-9M | $-4M |